Milestone Pharmaceuticals
MIST • NASDAQ
Milestone Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph G. Oliveto, with a market cap of $122.4M.
Market Cap$122.4M
Employees47.0
CEOJoseph G. Oliveto
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Milestone Pharmaceuticals FAQ
Common questions about Milestone Pharmaceuticals
Milestone Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $75.1M.
Milestone Pharmaceuticals has approximately 47 employees.